id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-300517-41pr3dwa	Zhang, Dan	The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence	2020-05-05		.txt	text/plain	4771	220	32	As recommended in the Guideline on Diagnosis and Treatment of Coronavirus Disease 2019 (Revised 7th version) which was officially released by National Health Commission of the People's Republic of China, TCM could exert favorable effects for patients with different syndromes and distinct stages of COVID-19, contributing to infections in the periods of both medical observation and clinical treatment [23] . In addition, prevenient Chinese research pointed out its clinical J o u r n a l P r e -p r o o f advantages that were related to improve respiratory symptoms, inhibit concurrent bacterial infection, and regulate immune function, superior clinical safety, especially certain hepatoprotective effects, suggesting it might have potentials to relieve some drug-induced liver injury during the treatment of COVID-19 for serious cases [60] .	./cache/cord-300517-41pr3dwa.txt	./txt/cord-300517-41pr3dwa.txt